IS ALTERNATE-DAY ADD-ON SEIZURE TREATMENT WITH CLOBAZAM EFFECTIVE AND SAFE - A PILOT TRIAL

被引：0
|
作者：
SCHMIDT, D
FROSCHER, F
STODIECK, SRG
机构：
来源：
EPILEPSIA | 1995年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [1] CLOBAZAM FOR REFRACTORY CHILDHOOD SEIZURE DISORDERS - A VALUABLE ADD-ON DRUG
    MUNN, R
    CAMFIELD, C
    CAMFIELD, P
    DOOLEY, J
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1987, 14 (02) : 205 - 205
  • [2] CLOBAZAM FOR REFRACTORY CHILDHOOD SEIZURE DISORDERS - A VALUABLE ADD-ON DRUG
    CAMFIELD, PR
    CAMFIELD, CS
    MUNN, R
    DOOLEY, JM
    ANNALS OF NEUROLOGY, 1987, 22 (03) : 416 - 416
  • [3] Clobazam: An effective add-on therapy in refractory status epilepticus
    Sivakumar, Sanjeev
    Ibrahim, Mohammad
    Parker, Dennis, Jr.
    Norris, Gregory
    Shah, Aashit
    Mohamed, Wazim
    EPILEPSIA, 2015, 56 (06) : e83 - e89
  • [4] CLOBAZAM ADD-ON THERAPY FOR THE TREATMENT OF EPILEPTIC ENCEPHALOPATHY
    Lee, E. H.
    Jeong, M. H.
    Ko, T-S
    EPILEPSIA, 2010, 51 : 71 - 71
  • [5] Alternate-day add-on therapy with dapagliflozin in patients with type 2 diabetes mellitus: potential benefits and concerns
    Singh, Harmanjit
    Joshi, Dinesh
    Narula, Seerat
    Singla, Mandeep
    Rohilla, Ravi
    Singh, Jagjit
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (02) : 197 - 203
  • [6] Alternate-Day Fasting Gets a Safe Bill of Health
    Heilbronn, Leonie K.
    Panda, Satchidananda
    CELL METABOLISM, 2019, 30 (03) : 411 - 413
  • [7] CLOBAZAM AS AN ADD-ON DRUG IN THE TREATMENT OF REFRACTORY EPILEPSY OF CHILDHOOD
    KEENE, DL
    WHITING, S
    HUMPHREYS, P
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1990, 17 (03) : 317 - 319
  • [8] Alternate-day calcium dosing may be an effective treatment option for chronic hypoparathyroidism
    Akkan, T.
    Dagdeviren, M.
    Koca, A. O.
    Ertugrul, D. T.
    Altay, M.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2020, 43 (06) : 853 - 858
  • [9] Alternate-day calcium dosing may be an effective treatment option for chronic hypoparathyroidism
    T. Akkan
    M. Dagdeviren
    A. O. Koca
    D. T. Ertugrul
    M. Altay
    Journal of Endocrinological Investigation, 2020, 43 : 853 - 858
  • [10] MEMBRANOUS NEPHROPATHY ALTERNATE-DAY TREATMENT WITH PREDNISONE
    TU, WH
    HOPPER, J
    BIAVA, CG
    KIDNEY INTERNATIONAL, 1979, 16 (06) : 939 - 939
12345